Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael C Wendl

Showing results (61-70 of 95) with videos related to

Pageof 10
Sort By:
Nature Communications|May 8, 2021
Co-evolution of tumor and immune cells during progression of multiple myelomaRuiyang Liu, Qingsong Gao, Steven M Foltz, et al.
Cancer Research|February 13, 2023
Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple MyelomaLijun Yao, Julia T Wang, Reyka G Jayasinghe, et al.
Cell|April 7, 2018
Perspective on Oncogenic Processes at the End of the Beginning of Cancer GenomicsLi Ding, Matthew H Bailey, Eduard Porta-Pardo, et al.
Genome Research|April 18, 2015
Characteristics of de novo structural changes in the human genomeWigard P Kloosterman, Laurent C Francioli, Fereydoun Hormozdiari, et al.
Cancer Research Communications|March 27, 2023
Comprehensive Characterization of the Multiple Myeloma Immune Microenvironment Using Integrated scRNA-seq, CyTOF, and CITE-seq AnalysisLijun Yao, Reyka G Jayasinghe, Brian H Lee, et al.
Cancer Research|December 15, 2023
Combining the Tyrosine Kinase Inhibitor Cabozantinib and the mTORC1/2 Inhibitor Sapanisertib Blocks ERK Pathway Activity and Suppresses Tumor Growth in Renal Cell CarcinomaYige Wu, Siqi Chen, Xiaolu Yang, et al.
Nature Communications|May 17, 2023
Author Correction: Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinomaYige Wu, Nadezhda V Terekhanova, Wagma Caravan, et al.
Nature Communications|March 27, 2023
Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinomaYige Wu, Nadezhda V Terekhanova, Wagma Caravan, et al.
Nature Communications|March 29, 2017
Proteogenomic integration reveals therapeutic targets in breast cancer xenograftsKuan-Lin Huang, Shunqiang Li, Philipp Mertins, et al.
Cell Genomics|January 23, 2026
Cellular senescence in human liver under normal aging and cancerAlla Karpova, Xiang Li, Chien-Wei Peng, et al.
Pageof 10

Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
Nature Communications|May 8, 2021
Co-evolution of tumor and immune cells during progression of multiple myelomaRuiyang Liu, Qingsong Gao, Steven M Foltz, et al.
Cancer Research|February 13, 2023
Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple MyelomaLijun Yao, Julia T Wang, Reyka G Jayasinghe, et al.
Cell|April 7, 2018
Perspective on Oncogenic Processes at the End of the Beginning of Cancer GenomicsLi Ding, Matthew H Bailey, Eduard Porta-Pardo, et al.
Genome Research|April 18, 2015
Characteristics of de novo structural changes in the human genomeWigard P Kloosterman, Laurent C Francioli, Fereydoun Hormozdiari, et al.
Cancer Research Communications|March 27, 2023
Comprehensive Characterization of the Multiple Myeloma Immune Microenvironment Using Integrated scRNA-seq, CyTOF, and CITE-seq AnalysisLijun Yao, Reyka G Jayasinghe, Brian H Lee, et al.
Cancer Research|December 15, 2023
Combining the Tyrosine Kinase Inhibitor Cabozantinib and the mTORC1/2 Inhibitor Sapanisertib Blocks ERK Pathway Activity and Suppresses Tumor Growth in Renal Cell CarcinomaYige Wu, Siqi Chen, Xiaolu Yang, et al.
Nature Communications|May 17, 2023
Author Correction: Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinomaYige Wu, Nadezhda V Terekhanova, Wagma Caravan, et al.
Nature Communications|March 27, 2023
Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinomaYige Wu, Nadezhda V Terekhanova, Wagma Caravan, et al.
Nature Communications|March 29, 2017
Proteogenomic integration reveals therapeutic targets in breast cancer xenograftsKuan-Lin Huang, Shunqiang Li, Philipp Mertins, et al.
Cell Genomics|January 23, 2026
Cellular senescence in human liver under normal aging and cancerAlla Karpova, Xiang Li, Chien-Wei Peng, et al.
Pageof 10